LNR < 2.62 (n = 102) | LNR ≥ 2.62 (n = 18) | P-value | |
---|---|---|---|
Age (years) | 57.7 ± 16.0 | 59.5 ± 14.7 | 0.763 |
Sex | |||
Female | 59 | 12 | 0.483 |
Male | 43 | 6 | |
Albumin (g/L) | 3.98 ± 0.40 | 4.01 ± 0.41 | 0.915 |
Tumor size (mm) | 19.0 ± 19.4 | 22.6 ± 15.1 | 0.194 |
Surgical margin status | |||
R0 | 99 | 17 | 0.569 |
R1 | 3 | 1 | |
Tumor location | |||
Head | 39 | 8 | 0.595 |
Body/tail | 58 | 10 | |
Multiple | 5 | 0 | |
Ki-67 | 3.14 ± 3.83 | 5.46 ± 6.97 | 0.042 |
Clinical stage | |||
I | 64 | 10 | 0.714 |
II | 23 | 4 | |
III | 25 | 4 | |
2017 WHO classification | |||
G1 | 64 | 9 | 0.361 |
G2 | 37 | 8 | |
G3 | 1 | 1 | |
Hormonal function | |||
No | 56 | 14 | 0.070 |
Yes | 46 | 4 | |
Lymph node metastasis | |||
No | 88 | 14 | 0.352 |
Yes | 14 | 4 | |
Lymphatic invasion | |||
No | 88 | 17 | 0.334 |
Yes | 14 | 1 | |
Venous invasion | |||
No | 77 | 14 | 0.834 |
Yes | 25 | 4 |